May 8, 2026 TELUS Announces Retirement of Chief Financial Officer Doug French and Appointment of Successor Gopi Chande
May 8, 2026 The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA
